Document:

sens_Ex4_7

		
			Exhibit 4.7
		

		
			 
		

		
			DESCRIPTION OF SENSEONICS HOLDINGS, INC. COMMON STOCK
		

		
			 
		

		
			 
		

		
			The following description of the common stock of Senseonics Holdings, Inc., or the Company, is a summary and does not purport to be complete. This summary is qualified in its entirety by reference to the provisions of the Delaware General Corporation Law, or the DGCL, and the complete text of the Company’s amended and restated certificate of incorporation, or the restated certificate, and amended and restated bylaws, or the bylaws, each as currently in effect, which are incorporated by reference as Exhibits 3.1 and 3.2, respectively, of the Company’s Annual Report on Form 10-K, to which this description is also an exhibit. The Company encourages you to read that law and those documents carefully.
		

		
			 
		

		
			Common Stock
		

		
			 
		

		
			Authorized Capital Stock
		

		
			 
		

		
			The restated certificate authorizes the issuance of up to 450,000,000 shares of common stock, $0.001 par value per share, and 5,000,000 shares of preferred stock, $0.001 par value per share. The Company’s board of directors may establish the rights and preferences of the preferred stock from time to time. 
		

		
			 
		

		
			 
		

		
			Voting Rights
		

		
			 
		

		
			Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Under the restated certificate and bylaws, common stockholders do not have cumulative voting rights. Because of this, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they should so choose.
		

		
			 
		

		
			Dividends
		

		
			 
		

		
			Holders of common stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.
		

		
			 
		

		
			Liquidation
		

		
			 
		

		
			In the event of the Company’s liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders.
		

		
			 
		

		
			 
		

		
			Rights and Preferences
		

		
			 
		

		
			

		 

		

		
			Holders of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.
		

		
			 
		

		
			 
		

		
			Antitakeover Effects of Provisions of Charter Documents and Delaware Law
		

		
			 
		

		
			Charter Documents
		

		
			 
		

		
			The Company’s restated certificate and bylaws, each as amended to date, include a number of provisions that may have the effect of deterring hostile takeovers or delaying or preventing changes in control or management of the Company. First, the Company’s board of directors is classified into three classes of directors. Under Delaware law, directors of a corporation with a classified board may be removed only for cause unless the corporation's certificate of incorporation provides otherwise. The restated certificate does not provide otherwise. In addition, the restated certificate provides that all stockholder action must be effected at a duly called meeting of stockholders and not by a consent in writing. Further, the bylaws limit who may call special meetings of the stockholders. The restated certificate does not include a provision for cumulative voting for directors. Under cumulative voting, a minority stockholder holding a sufficient percentage of a class of shares may be able to ensure the election of one or more directors. Finally, the bylaws establish procedures, including advance notice procedures, with regard to the nomination of candidates for election as directors and stockholder proposals. These and other provisions of the restated certificate and bylaws and Delaware law could discourage potential acquisition proposals and could delay or prevent a change in control or management of the Company.
		

		
			 
		

		
			Delaware Takeover Statute
		

		
			 
		

		
			The Company is subject to Section 203 of the DGCL, which regulates acquisitions of some Delaware corporations. Section 203 generally prohibits a publicly held Delaware corporation from engaging in a "business combination" with an "interested stockholder" for a period of three years following the date of the transaction in which the person became an interested stockholder, unless:
		

		
			 
		

			
	
			
				 ·
			

			
	
			
			the board of directors of the corporation approved the business combination or the other transaction in which the person became an interested stockholder prior to the date of the business combination or other transaction;

		
			 
		

			
	
			
				 ·
			

			
	
			
			upon consummation of the transaction that resulted in the person becoming an interested stockholder, the person owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by persons who are directors and also officers of the corporation and shares issued under employee stock plans under which employee participants do not have the right to determine 

		 

	confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

		
			 
		

			
	
			
				 ·
			

			
	
			
			on or subsequent to the date the person became an interested stockholder, the board of directors of the corporation approved the business combination and the stockholders of the corporation authorized the business combination at an annual or special meeting of stockholders by the affirmative vote of at least 66-2/3% of the outstanding stock of the corporation not owned by the interested stockholder.

		
			 
		

		
			Section 203 of the DGCL defines a "business combination" to include any of the following:
		

		
			 
		

			
	
			
				 ·
			

			
	
			
			any merger or consolidation involving the corporation and the interested stockholder;

		
			 
		

			
	
			
				 ·
			

			
	
			
			any sale, transfer, pledge or other disposition of 10% or more of the corporation's assets or outstanding stock involving the interested stockholder;

		
			 
		

			
	
			
				 ·
			

			
	
			
			subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any of its stock to the interested stockholder;

		
			 
		

			
	
			
				 ·
			

			
	
			
			any transaction involving the corporation that has the effect of increasing the proportionate share of its stock owned by the interested stockholder; or

		
			 
		

			
	
			
				 ·
			

			
	
			
			the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

			
	
			
				 ·
			

			
	
			
			In general, Section 203 defines an "interested stockholder" as any person who, together with the person's affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation's voting stock.

		
			 
		

		
			Section 203 of the DGCL could depress the Company’s stock price and delay, discourage or prohibit transactions not approved in advance by the board of directors, such as takeover attempts that might otherwise involve the payment to the Company’s stockholders of a premium over the market price of the its common stock.
		

		
			 
		

		
			Transfer Agent and Registrar
		

		
			 
		

		
			The transfer agent and registrar for the Company’s common stock is Computershare Trust Company, N.A. The transfer agent's address is 250 Royall Street, Canton, Massachusetts 02021.
		

		
			 
		

		
			 
		

		
			Listing on the NYSE American
		

		
			 
		

		
			The Company’s common stock is listed on the NYSE American under the symbol "SENS."sens_Ex10_31

		

			CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED

		

		
			 
		

		
			FIFTH AMENDMENT TO DISTRIBUTION AGREEMENT
		

		
			 
		

		
			This Fifth Amendment to Distribution Agreement (the “Fifth Amendment”) is effective as of December 12, 2019 (the “Fifth Amendment Effective Date”), by and between Roche Diagnostics International AG, Basel Branch Diabetes Care, with offices located at Peter Merian-Weg 4, 4052 Basel, Switzerland (“Roche Diagnostics”) and Roche Diabetes Care GmbH, with offices located at Sandhofer Strasse 116, 68305 Mannheim, Germany (“Roche Diabetes” and collectively with Roche Diagnostics, “ROCHE”) and Senseonics, Incorporated, with offices located at 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, USA (“SENSEONICS”).  ROCHE and SENSEONICS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
		

		
			 
		

		
			WHEREAS, ROCHE and SENSEONICS are parties to that certain Distribution Agreement dated May 23, 2016 (as amended, the “Agreement”), as amended from time to time including the Amendments to Distribution Agreement dated as of November 28, 2016 (the “First Amendment”),  April 11, 2018 (the “Second Amendment”),  December 20, 2018 (the “Third Amendment”) and January 31, 2019 (the “Fourth Amendment”); and
		

		
			 
		

		
			WHEREAS, the Parties desire to amend the Agreement in accordance with Section 11.11 thereof in order to reduce the Minimum Requirement for 2020;
		

		
			 
		

		
			NOW THEREFORE, in consideration of the premises and mutual covenants contained in the Fifth Amendment, the Parties agree as follows:
		

		
			 
		

		
			 
		

		
			The Parties agree that the table shown on page 7 of the Fourth Amendment, Exhibit 4 regarding the Minimum Requirement for 2019 – 2020 (units) shall be amended as follows:
		

		
			 
		

		
			 
		

		
			Minimum Requirement for 2019 – 2020 (units)
		

		
			 
		

			
					
						 

					
					
						Eversense® XL Sensor Pack

					
					
						Eversense® XL Smart Transmitter Pack

				
	
					
						2019

					
					
						[***]    

					
					
						[***]

				
	
					
						2020

					
					
						[***]

					
					
						[***]

				

		
			 
		

		
			Furthermore, the Parties would like to amend Section 1.c of the Fourth Amendment, Exhibit 4 as follows: 
		

		
			 
		

		
			1.c 2020 Pricing shall be [***] per Eversense XL Senor Pack.
		

		
			 
		

		
			 
		

		
			 
		

		
			[Remainder of Page Intentionally Blank]
		

		
			

		

		
			 
		

		
			 
		

		
			 
		

		
			IN WITNESS WHEREOF, each of the Parties has caused this Fifth Amendment to be executed by its duly authorized representative as of the Fifth Amendment Effective Date.
		

		
			 
		

		
			Senseonics, Incorporated   
		

		
			 
		

		
			By:  _____/s/ Tim Goodnow___________
		

		
			 
		

		
			Name:_____Tim Goodnow______________
		

		
			 
		

		
			Title:______President & CEO___________
		

		
			 
		

		
			Roche Diagnostics International AG
		

		
			Basel Branch Diabetes Care
		

		
			 
		

		
			By:  ___/s/ Marcel Gmeunder ________
		

		
			 
		

		
			Name:___Marcel Gmeunder___________
		

		
			 
		

		
			Title:___CEO Diabetes Care___________
		

		
			 
		

		
			 
		

		
			By:  ____/s/ Edwin Sonnenschein ______
		

		
			 
		

		
			Name:____Edwin Sonnenschein_________
		

		
			 
		

		
			Title:____Head Legal DC______________
		

		
			 
		

		
			Roche Diabetes Care GmbH
		

		
			 
		

		
			By:  ____/s/ Edwin Sonnenschein ______
		

		
			 
		

		
			Name:____Edwin Sonnenschein_________
		

		
			 
		

		
			Title:____Head Legal DC______________
		

		
			 
		

		
			 
		

		
			By:  ____/s/ P. Hoffman______________
		

		
			 
		

		
			Name:_____ P. Hoffman _______________
		

		
			 
		

		
			Title:_____ Head Legal DC ____________
		

		
			 
		

		 

		

			1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]